Market Cap

AbCellera Biologics Inc. Market Capitalization:

$1.03 Billion

USD as of Jan. 1, 2026

business AbCellera Biologics Inc. Company Profile

AbCellera Biologics Inc. Main Stock Listing

NASDAQ: ABCL

Market Capitalization History of AbCellera Biologics Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of AbCellera Biologics Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2026 $1.03 B 21.33%
Jan. 1, 2025 $846.2 M -50.06%
Jan. 1, 2024 $1.69 B -38.24%
Jan. 1, 2023 $2.74 B 5.78%
Jan. 1, 2022 $2.59 B -82.98%
Jan. 1, 2021 $15.24 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

AbCellera Biologics Inc. Categories

Canada languages Healthcare languages Biotechnology
Canada Healthcare Canada Biotechnology

Stocks & Indices

AbCellera Biologics Inc. has the following listings and related stock indices.


Stock: NASDAQ: ABCL

Stock: FSX: 8QQ

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.